Abstract
OP09 Anti TNF-α therapy is a major cost driver in inflammatory bowel disease: Results from the COIN study
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s1873-9946(12)60010-5
Copy DOIJournal: Journal of Crohn's and Colitis | Publication Date: Feb 1, 2012 |
Citations: 1 |
OP09 Anti TNF-α therapy is a major cost driver in inflammatory bowel disease: Results from the COIN study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.